===================== Product Identification =====================
MSDS NAME:40655 HEPARIN SODIUM INJECTION USP
NIIN:01-030-3254
MSDS Number: BWKXG
=== Responsible Party ===
Company:UPJOHN CO THE
Address:7171 PORTAGE RD
City:KALAMAZOO
State:MI
ZIP:49001-0199
Country:US
Info Phone Num:616-323-7555
Emergency Phone Num:616-323-7555(D)/616-323-5122(24 HR)
CAGE:GO374
=== Contractor Identification ===
Company:PHARMACIA & UPJOHN
Address:7171 PORTAGE RD
Box:City:KALAMAZOO
State:MI
ZIP:49001-0199
Country:US
Phone:616-833-5122/616-833-7555
CAGE:93703
Company:UPJOHN CO THE
Address:7171 PORTAGE RD
City:KALAMAZOO
State:MI
ZIP:49001-0199
Country:US
Phone:616-323-7555
CAGE:GO374
============= Composition/Information on Ingredients =============
Name:SODIUM HEPARIN 1000-10,000 (UNITS/ML DEPENDENT ON
CONCENTRATION)
CAS:9041-08-1
RTECS #:MI0850000
Name:WATER
CAS:7732-18-5
RTECS #:ZC0110000
Fraction by Wt: <98%
Name:NON HAZARDOUS INGREDIENTS
Fraction by Wt: <2%
===================== Hazards Identification =====================
LD50 LC50 Mixture:ORAL LD50 (MOUSE): >5 G/KG (SEE SUPP)
Routes of Entry: Inhalation:YES Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:HEPARIN SODIUM-SKIN: IRRITATION &
SENSITIZATION. INHALATION: 12-18 MG/KG CAUSES IMPAIRED BLOOD
COAGULATION. MAY CAUSE HEMORRHAGE, IRRITATION AT INJECTION SITE,
HYPERSENSITIVITY.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:HEPARIN SODIUM-IRRITATION, CHILLS, FEVER,
URTICARIA, ASTHMA, RHINITIS, LACRIMATION, HEADACHE, NAUSEA,
VOMITING, ANAPHYLACTOID REACTIONS.
Medical Cond Aggravated by Exposure:HYPERSENSITIVITY TO HEPARIN, LIVER
DISEASE, IMPAIRED HEMOSTASIS, SEVERE THROMBOCYTOPENIA/HYPERTENSION,
ULCERATIVE LESIONS, HEMOPHILIA, VASCULAR PURPURAS, CONCURRENT ORAL
ANTICOAGULANT THERAPY.
======================= First Aid Measures =======================
Eyes: FLUSH W/WATER FOR 15 MINS. SKIN: WASH W/SOAP & WATER.
INHALATION: REMOVE TO FRESH AIR. OBTAIN MEDICAL ATTENTION IN ALL
CASES.
===================== Fire Fighting Measures =====================
Flash Point:NON-FLAMMABLE
Extinguishing Media:WATER, CO2, DRY CHEMICAL.
Fire Fighting Procedures:WEAR SELF CONTAINED BREATHING APPARATUS & FULL
BODY PROTECTIVE EQUIPMENT.
Unusual Fire/Explosion Hazard:NONE
================== Accidental Release Measures ==================
Spill Release Procedures:PROVIDE VENTILATION & PERSONAL PROTECTIVE
EQUIPMENT. KEEP PRODUCT OUT OF DRAINS & PREVENT ENTRY TO
SURFACE/GROUNDWATER & SOIL. SMALL: ABSORB W/PAPER
TOWELS/APPROPRIATE MEDIA. LARGE: VACUUM/SCOOP UP & PLACE IN A
SUITABLE CONTAINER.
====================== Handling and Storage ======================
Handling and Storage Precautions:STORE IN A COOL, DRY PLACE & PROTECT
FROM LIGHT.
Other Precautions:AVOID CONTACT W/SKIN, EYES & CLOTHING. KEEP OUT OF
REACH OF CHILDREN.
============= Exposure Controls/Personal Protection =============
Respiratory Protection:NONE REQUIRED
Ventilation:LOCAL EXHAUST
Protective Gloves:RUBBER
Eye Protection:SAFETY GLASSES W/SIDE SHIELDS
Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE
REUSE. WASH THOROUGHLY AFTER HANDLING.
Supplemental Safety and Health
ORAL LD50 INFORMATION IS FOR HEPARIN SODIUM. PRESCRIPTION DRUG USED IN
ANTICOAGULANT THERAPY IN PROPHYLAXIS, TREATMENT OF ARTERIAL/VENOUS
THROMBOSIS/PULMONARY EMBOLISM/DISSEMINATED INTRAVASCULAR COAGU
LATION, TO PREVENT CLOTTING IN ARTERIAL/CARDIAC SURGERY, AS
ANTICOAGULANT IN BLOOD TRANSFUSIONS/SAMPLES.
================== Physical/Chemical Properties ==================
Solubility in Water:COMPLETE
Appearance and Odor:LIQUID IN 1-, 4-, 5-, 10-, 30-ML VIALS.
================= Stability and Reactivity Data =================
Stability Indicator/Materials to Avoid:YES
NONE
Stability Condition to Avoid:LIGHT
Hazardous Decomposition Products:CO, CO2, NITROGEN & SULFUR OXIDES.
==================== Disposal Considerations ====================
Waste Disposal Methods:DISPOSE OF BY INCINERATION IAW/INTERNATIONAL,
FEDERAL, STATE & LOCAL REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
*** END OF RECORD *** |
|
|